BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 25406834)

  • 41. HU-331 is a catalytic inhibitor of topoisomerase IIα.
    Regal KM; Mercer SL; Deweese JE
    Chem Res Toxicol; 2014 Dec; 27(12):2044-51. PubMed ID: 25409338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A mouse model for studying the interaction of bisdioxopiperazines with topoisomerase IIalpha in vivo.
    Grauslund M; Thougaard AV; Füchtbauer A; Hofland KF; Hjorth PH; Jensen PB; Sehested M; Füchtbauer EM; Jensen LH
    Mol Pharmacol; 2007 Oct; 72(4):1003-14. PubMed ID: 17622580
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative effects of doxorubicin and a doxorubicin analog, 13-deoxy, 5-iminodoxorubicin (GPX-150), on human topoisomerase IIβ activity and cardiac function in a chronic rabbit model.
    Frank NE; Cusack BJ; Talley TT; Walsh GM; Olson RD
    Invest New Drugs; 2016 Dec; 34(6):693-700. PubMed ID: 27581956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the molecular basis of doxorubicin-induced cardiotoxicity.
    Zhang S; Liu X; Bawa-Khalfe T; Lu LS; Lyu YL; Liu LF; Yeh ET
    Nat Med; 2012 Nov; 18(11):1639-42. PubMed ID: 23104132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of Action and Reduced Cardiotoxicity of Pixantrone; a Topoisomerase II Targeting Agent with Cellular Selectivity for the Topoisomerase IIα Isoform.
    Hasinoff BB; Wu X; Patel D; Kanagasabai R; Karmahapatra S; Yalowich JC
    J Pharmacol Exp Ther; 2016 Feb; 356(2):397-409. PubMed ID: 26660439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy.
    Atwal M; Lishman EL; Austin CA; Cowell IG
    Mol Pharmacol; 2017 Jan; 91(1):49-57. PubMed ID: 27974636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients.
    Schuler MK; Gerdes S; West A; Richter S; Busemann C; Hentschel L; Lenz F; Kopp HG; Ehninger G; Reichardt P; Pink D
    BMC Cancer; 2016 Aug; 16():619. PubMed ID: 27507014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
    Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
    Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
    Nikolényi A; Sükösd F; Kaizer L; Csörgo E; Vörös A; Uhercsák G; Ormándi K; Lázár G; Thurzó L; Brodowicz T; Kahán Z
    Oncology; 2011; 80(3-4):269-77. PubMed ID: 21734419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of O⁶-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells.
    Raguz S; Adams C; Masrour N; Rasul S; Papoutsoglou P; Hu Y; Cazzanelli G; Zhou Y; Patel N; Coombes C; Yagüe E
    Biochem Pharmacol; 2013 Jan; 85(2):186-96. PubMed ID: 23122841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac.
    Wartlick F; Bopp A; Henninger C; Fritz G
    Biochim Biophys Acta; 2013 Dec; 1833(12):3093-3103. PubMed ID: 23999236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells.
    Saffi J; Agnoletto MH; Guecheva TN; Batista LF; Carvalho H; Henriques JA; Stary A; Menck CF; Sarasin A
    DNA Repair (Amst); 2010 Jan; 9(1):40-7. PubMed ID: 19926538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs.
    Chen W; Qiu J; Shen YM
    Drug Discov Ther; 2012 Oct; 6(5):230-7. PubMed ID: 23229142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues.
    Duran GE; Lau DH; Lewis AD; Kühl JS; Bämmler TK; Sikic BI
    Cancer Chemother Pharmacol; 1996; 38(3):210-6. PubMed ID: 8646794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytogenetic evidence that DNA topoisomerase II is not involved in radiation induced chromsome-type aberrations.
    Mosesso P; Pepe G; Ottavianelli A; Schinoppi A; Cinelli S
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():14-8. PubMed ID: 26520368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioflavonoids as poisons of human topoisomerase II alpha and II beta.
    Bandele OJ; Osheroff N
    Biochemistry; 2007 May; 46(20):6097-108. PubMed ID: 17458941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.
    Moretti E; Desmedt C; Biagioni C; Regan MM; Oakman C; Larsimont D; Galardi F; Piccart-Gebhart M; Sotiriou C; Rimm DL; Di Leo A
    Future Oncol; 2013 Oct; 9(10):1477-87. PubMed ID: 24106899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alpha.
    Bau JT; Kurz EU
    Biochem Pharmacol; 2011 Feb; 81(3):345-54. PubMed ID: 20959117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.
    Boland MP; Fitzgerald KA; O'Neill LA
    J Biol Chem; 2000 Aug; 275(33):25231-8. PubMed ID: 10940316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species.
    Wu X; Hasinoff BB
    Anticancer Drugs; 2005 Jan; 16(1):93-9. PubMed ID: 15613911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.